Differential regulation of inflammation and immunity in mild and severe experimental asthma

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Sagar, Seil ^a,b   Verheijden, Kim A T ^a   Georgiou, Niki A ^b   Garssen, Johan ^a,b   Kraneveld, Aletta D ^a   Vos, Arjan P ^b   Folkerts, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OVALBUMIN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRINITROPHENYL; TRINITROPHENYL-OVALBUMIN; TRINITROPHENYL OVALBUMIN;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; IMMUNITY; IMMUNOLOGY; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT;

MUS;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; IMMUNITY; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PNEUMONIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84879292825     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/808470     Document Type: Article

References (39)

1. Gamble J., Stevenson M., McClean E., Heaney L. G., The prevalence of nonadherence in difficult asthma. The American Journal of Respiratory and Critical Care Medicine 2009 180 9 817 822 2-s2.0-70350458755 10.1164/rccm.200902-0166OC
2. Boyce J. A., Bochner B., Finkelman F. D., Rothenberg M. E., Advances in mechanisms of asthma, allergy, and immunology in 2011. Journal of Allergy and Clinical Immunology 2011 129 2 335 341 10.1016/j.jaci.2011.01.027
3. Holgate S. T., Innate and adaptive immune responses in asthma. Nature Medicine 18 5 673 683
4. Fahy J. V., Eosinophilic and neutrophilic inflammation in asthma insights from clinical studies. Proceedings of the American Thoracic Society 2009 6 3 256 259 2-s2.0-67049144615 10.1513/pats.200808-087RM
5. Agache I., Akdis C., Jutel M., Virchow J. C., Untangling asthma phenotypes and endotypes. Allergy 67 7 835 846
6. Bogaert P., Tournoy K. G., Naessens T., Grooten J., Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma. The American Journal of Pathology 2009 174 1 3 13 2-s2.0-58249118714 10.2353/ajpath.2009.071151
7. Ospelt C., Gay S., TLRs and chronic inflammation. International Journal of Biochemistry and Cell Biology 2010 42 4 495 505 2-s2.0-77649180575 10.1016/j.biocel.2009.10.010
8. Chen K., Xiang Y., Yao X., Liu Y., Gong W., Yoshimura T., Wang J. M., The active contribution of toll-like receptors to allergic airway inflammation. International Immunopharmacology 2011 11 10 1391 1398 10.1016/j.intimp.2011.05. 003
9. Uehara A., Fujimoto Y., Fukase K., Takada H., Various human epithelial cells express functional toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Molecular Immunology 2007 44 12 3100 3111 2-s2.0-34247239745 10.1016/j.molimm.2007.02.007
10. Iwasaki A., Medzhitov R., Toll-like receptor control of the adaptive immune responses. Nature Immunology 2004 5 10 987 995 2-s2.0-5444262511 10.1038/ni1112
11. Barnes P. J., The cytokine network in asthma and chronic obstructive pulmonary disease. Journal of Clinical Investigation 2008 118 11 3546 3556 2-s2.0-55849148482 10.1172/JCI36130
12. Zuberi R. I., Apgar J. R., Chen S. S., Liu F. T., Role for IgE in airway secretions: IgE immune complexes are more potent inducers than antigen alone of airway inflammation in a murine model. Journal of Immunology 2000 164 5 2667 2673 2-s2.0-0034162549
13. Dahlin J. S., Ivarsson M. A., Heyman B., Hallgren J., IgE immune complexes stimulate an increase in lung mast cell progenitors in a mouse model of allergic airway inflammation. PLoS ONE 2011 6 5 2-s2.0-79956281999 10.1371/journal.pone.0020261 e20261
14. Heine H., TLRs, NLRs and RLRs: innate sensors and their impact on allergic diseases-a current view. Immunology Letters 2011 139 1-2 14 24 2-s2.0-79960698273 10.1016/j.imlet.2011.04.010
15. Eder W., Klimecki W., Yu L., von Mutius E., Riedler J., Braun-Fahrländer C., Nowak D., Martinez F. D., Toll-like receptor 2 as a major gene for asthma in children of European farmers. Journal of Allergy and Clinical Immunology 2004 113 3 482 488 2-s2.0-1542721504 10.1016/j.jaci.2003.12. 374
16. Reece P., Thanendran A., Crawford L., Tulic M. K., Thabane L., Prescott S. L., Sehmi R., Denburg J. A., Maternal allergy modulates cord blood hematopoietic progenitor toll-like receptor expression and function. Journal of Allergy and Clinical Immunology 2011 127 2 447 453 2-s2.0-79551478150 10.1016/j.jaci.2010.11.006
17. Kormann M. S. D., Ferstl R., Depner M., Klopp N., Spiller S., Illig T., Vogelberg C., Von Mutius E., Kirschning C. J., Kabesch M., Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. Allergy 2009 64 4 636 642 2-s2.0-62449126550 10.1111/j.1398-9995.2008.01891.x
18. Stowell N. C., Seideman J., Raymond H. A., Smalley K. A., Lamb R. J., Egenolf D. D., Bugelski P. J., Murray L. A., Marsters P. A., Bunting R. A., Flavell R. A., Alexopoulou L., San Mateo L. R., Griswold D. E., Sarisky R. T., Mbow M. L., Das A. M., Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respiratory Research 2009 10 article 43 2-s2.0-70249120405 10.1186/1465-9921-10-43
19. Mizel S. B., Honko A. N., Moors M. A., Smith P. S., West A. P., Induction of macrophage nitric oxide production by gram-negative flagellin involves signaling via heteromeric toll-like receptor 5/toll-like receptor 4 complexes. Journal of Immunology 2003 170 12 6217 6223 2-s2.0-0037604765
20. Dong L., Li H., Wang S., Li Y., Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. Journal of Asthma 2009 46 3 229 233 2-s2.0-65449127398 10.1080/02770900802610050
21. Eisenbarth S. C., Piggott D. A., Huleatt J. W., Visintin I., Herrick C. A., Bottomly K., Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. Journal of Experimental Medicine 2002 196 12 1645 1651 2-s2.0-0037121946 10.1084/jem.20021340
22. Hammad H., Chieppa M., Perros F., Willart M. A., Germain R. N., Lambrecht B. N., House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nature Medicine 2009 15 4 410 416 2-s2.0-64149087970 10.1038/nm.1946
23. Møller-Larsen S., Nyegaard M., Haagerup A., Vestbo J., Kruse T. A., Børglum A. D., Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 2008 63 12 1064 1069 2-s2.0-57149098273 10.1136/thx.2007.094128
24. Gupta G. K., Agrawal D. K., CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma. BioDrugs 2010 24 4 225 235 2-s2.0-77954589298 10.2165/11536140-000000000-00000
25. Lachheb J., Dhifallah I. B., Chelbi H., Hamzaoui K., Hamzaoui A., Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens 2008 71 5 417 425 2-s2.0-42149153395 10.1111/j.1399-0039.2008.01011.x
26. Eder W., Klimecki W., Yu L., von Mutius E., Riedler J., Braun-Fahrländer C., Nowak D., Holst O., Martinez F. D., Association between exposure to farming, allergies and genetic variation in CARD4/NOD1. Allergy 2006 61 9 1117 1124 2-s2.0-33746846152 10.1111/j.1398-9995.2006.01128.x
27. Reijmerink N. E., Bottema R. W. B., Kerkhof M., Gerritsen J., Stelma F. F., Thijs C., van Schayck C. P., Smit H. A., Brunekreef B., Koppelman G. H., Postma D. S., TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy 2010 65 2 199 207 2-s2.0-73549100656 10.1111/j.1398-9995.2009.02111.x
28. Kabesch M., Peters W., Carr D., Leupold W., Weiland S. K., von Mutius E., Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. Journal of Allergy and Clinical Immunology 2003 111 4 813 817 2-s2.0-0037393553 10.1067/mai.2003.1336
29. Lloyd C. M., Hawrylowicz C. M., Regulatory T cells in asthma. Immunity 2009 31 3 438 449 2-s2.0-70049094943 10.1016/j.immuni.2009.08.007
30. Shi Y. H., Shi G. C., Wan H. Y., Jiang L. H., Ai X. Y., Zhu H. X., Tang W., Ma J. Y., Jin X. Y., Zhang B. Y., Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chinese Medical Journal 2011 124 13 1951 1956 2-s2.0-79960036625 10.3760/cma.j.issn.0366-6999.2011.13.006
31. Robinson D. S., The role of the T cell in asthma. Journal of Allergy and Clinical Immunology 126 6 1081 1091 10.1016/j.jaci.2010.06.025
32. Vale-Pereira S., Todo-Bom A., Geraldes L., Schmidt-Weber C., Akdis C. A., Mota-Pinto A., FoxP3, GATA-3 and T-bet expression in elderly asthma. Clinical and Experimental Allergy 2011 41 4 490 496 2-s2.0-79952599130 10.1111/j.1365-2222.2010.03640.x
33. Provoost S., Maes T., van Durme Y. M., Gevaert P., Bachert C., Schmidt-Weber C. B., Brusselle G. G., Joos G. F., Tournoy K. G., Decreased FOXP3 protein expression in patients with asthma. Allergy 2009 64 10 1539 1546 2-s2.0-70349200850 10.1111/j.1398-9995.2009.02056.x
34. Pasquier B., Launay P., Kanamaru Y., Moura I. C., Pfirsch S., Ruffié C., Hénin D., Benhamou M., Pretolani M., Blank U., Monteiro R. C., Identification of Fc α RI as an inhibitory receptor that controls inflammation: dual role of FcR γ ITAM. Immunity 2005 22 1 31 42 2-s2.0-19944430878 10.1016/j.immuni.2004.11.017
35. Chun E., Lee S. H., Lee S. Y., Shim E. J., Cho S. H., Min K. U., Kim Y. Y., Park H. W., Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. Journal of Clinical Immunology 2010 30 3 459 464 2-s2.0-77953285410 10.1007/s10875-009-9363-z
36. Keogh B., Parker A. E., Toll-like receptors as targets for immune disorders. Trends in Pharmacological Sciences 2011 32 7 435 442 2-s2.0-79959773879 10.1016/j.tips.2011.03.008
37. Clarke T. B., Davis K. M., Lysenko E. S., Zhou A. Y., Yu Y., Weiser J. N., Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Medicine 2010 16 2 228 231 2-s2.0-76249120134 10.1038/nm.2087
38. Finotto S., Glimcher L., T cell directives for transcriptional regulation in asthma. Springer Seminars in Immunopathology 2004 25 3-4 281 294 2-s2.0-1442283556 10.1007/s00281-003-0143-1
39. Mantel P. Y., Kuipers H., Boyman O., Rhyner C., Ouaked N., Rückert B., Karagiannidis C., Lambrecht B. N., Hendriks R. W., Crameri R., Akdis C. A., Blaser K., Schmidt-Weber C. B., GATA3-driven Th2 responses inhibit TGF- β 1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biology 2007 5 12, article e329 2-s2.0-38749147279 10.1371/journal.pbio.0050329